Diagnostics

“The second quarter saw a healthy improvement in the demand for Non-COVID business across all segments. The Company managed to…

Krsnaa Diagnostics Ltd (NSE:KRSNAA) Q2 FY23 Earnings Concall dated Nov. 10, 2022 Corporate Participants: Yash Prithviraj Mutha C.A. -- Whole-Time…

https://youtu.be/lAaNZKEvjOc Key highlights from Dr Lal PathLabs Ltd (LALPATHLAB) Q2 FY23 Earnings Concall Q&A Highlights: [00:16:43] Rahul Agarwal with Incred…

Dr. Lal PathLabs Ltd (NSE: LALPATHLAB), a leading provider of diagnostic and related healthcare services, has reported lower revenues and…

Stock Data Ticker: LALPATHLAB Exchange :     NSE BSE:         539524 Industry:      Diagnostic Price Performance Last 7 days             8.70% YTD                     -38.28% Last…

https://youtu.be/GyHJJGLWdjg Key highlights from Dr Lal PathLabs Ltd (LALPATHLAB) Q1 FY23 Earnings Concall Management Update: LALPATHLAB said it clocked the…

Overview Dr Lal PathLabs Limited is an Indian diagnostic company. It was incorporated in 1949. The headquarters is situated in Delhi,…

https://youtu.be/oafWwDciC8w Key highlights from Krsnaa Diagnostics Ltd (KRSNAA) Q4 FY22 Earnings Concall Q&A Highlights: Praveen Sahay of Edelweiss asked that…

https://youtu.be/XGfFd6kLFCE Key highlights from Dr Lal PathLabs Ltd (LALPATHLAB) Q4 FY22 Earnings Concall Management Update: LALPATHLAB said it saw significant…

https://www.youtube.com/watch?v=q_lILVipT-E Key highlights from Dr Lal PathLabs Ltd (LALPATHLAB) Q3 FY22 Earnings Concall Management Update: The company is enhancing access…

Diagnostic services have become the cornerstone of healthcare, especially for recommending treatments and monitoring post-treatment recovery. The diagnostics industry in…